Human Tissue Samples For Research
The Biosample Hub platform provides access to human tissue samples for research, and it provides something more: human biospecimens with reliable provenance information. In addition, biotech and pharma companies can use this platform to communicate directly with non-commercial biobanks who can provide them with human biospecimens direct from the source.
Moreover, Companies Access Biospecimens With Provenance
Biobanks Gain Direct Access To Industry
Biosample Hub makes biobanks visible to industry, through its simple and appealing platform. It also gives them the opportunity to make direct contact with companies. What’s more, the service is free of charge. Furthermore, it provides freedom from ethical concerns. As has been noted above, Biosample Hub offers complete financial transparency. In addition it allows full traceability of samples. Another key point is that the service is free of any contractual restrictions.
Patient Donations Of Tissue Samples Are Put To Good Use
Patients expect that researchers will use the tissue samples they donate for medical research. Significantly, Biosample Hub helps to ensure that patient expectations are met in two main ways:
(1) Improved biobank discoverability by companies that research new drugs, diagnostics, and vaccines. Accordingly, this results in less wastage of donated samples.
(2) Improved sample traceability that enables biobank staff to track the samples they provide. As a result, donors can have greater confidence that researchers will use their samples appropriately.
Mission: Improve Human Biospecimen Access
Mission: To connect Biotech and Pharma companies with non-commercial Biobanks. To allow the ethical provision of reliable human biospecimens with full provenance information
Vision: A global movement uniting Biotechs and Pharma with non-commercial Biobanks
Values: Free communication | Sample traceability | Not-for-profit
Why Biosample Hub Is Needed: Articles Making The Case
Why Hospital Biobanks Should Supply Biotechs. Drug Discovery & Development, September 13, 2021
The Challenges of Biosample Access and What Needs to Change. Labmate Online, September 10, 2021
The Challenge Of Solving A Huge Biotech Problem. Published in:
The Obstacles To Hospital Biobanks Supplying Biotechs. CPOstrategy, August 27, 2021
Biosample Provenance – What Researchers Need to Know and What Needs to Change. Labmate Online, August 10, 2021
Why Hospital Biobanks Need To Supply Industry – and Why There Is a Blockage in the System. Technology Networks, August 9, 2021
Connecting Biobanks With Biotech and Pharma Successfully. Technology Networks, July 20, 2021
Fix the pipeline for biological samples. ResearchProfessional News, July 14, 2021
Biosample Hub: making biobanks more accessible to industry. Health Tech World, July 6, 2021
Why the system for biospecimen procurement is broken. Drug Target Review, July 5, 2021
Are the business practices of commercial biospecimen brokers conducive to reliable and ethical biospecimen procurement? Business In The News, July 2021
The Business of Biospecimen Procurement needs to be Revised. The Journal of mHealth, July 5, 2021
Are the business practices of commercial biospecimen brokers conducive to reliable and ethical biospecimen procurement?. Healthcare Newsdesk, July 2, 2021
Do Commercial Biological Sample Broker Business Practices Help Procure Reliable and Ethical Biological Samples? Eminetra, July 2, 2021
The problem with biospecimen procurement. Scientist Live, June 28, 2021
Biosamples – business vs ethics. Health Tech World, June 24, 2021
We need to talk about biospecimen procurement. Manufacturing Chemist, June 24, 2021
Can business interest and reliable and ethical biospecimen procurement coexist? Pharmiweb.com, June 24, 2021